Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Abcore, Inc. is a leading biotechnology research and development company headquartered in the United States. Specialising in innovative solutions within the biotechnology sector, Abcore focuses on advancing scientific understanding and developing novel products outside the realm of nanobiotechnology. Since its founding in [year], the company has established a strong presence across major operational regions, supporting global research initiatives.
With a reputation for delivering high-quality research tools and customised services, Abcore’s core offerings include specialised antibodies, proteins, and assay development. Its commitment to scientific excellence and innovation has positioned Abcore as a trusted partner in the biotechnology industry, recognised for its contributions to advancing biomedical research and development.
-8 vs industry average
Abcore, Inc.’s score of 18 is lower than 45% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research and Development in Biotechnology (except Nanobiotechnology) has below-average carbon intensity
The Research and Development in Biotechnology (except Nanobiotechnology) industry has reduced its overall emissions by 19% since 2018
No reported emissions data is available for Abcore, Inc. yet.
Abcore, Inc., a research and development in biotechnology company headquartered in the US, has not publicly disclosed specific carbon emissions data for the most recent reporting periods. As such, detailed figures for Scope 1, Scope 2, or Scope 3 emissions are unavailable. Consequently, information regarding absolute emissions totals or specific reduction targets and achievements for Abcore, Inc. is also not available at this time.
While Abcore, Inc. does not report its own direct emissions, it operates within an industry that is increasingly focused on sustainability and reducing its environmental footprint. Companies in the biotechnology sector are often evaluating their supply chains and operational impacts to identify opportunities for emissions reductions. Without specific data, Abcore's climate commitments remain to be detailed publicly.
No climate goals have been disclosed for Abcore, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more